Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference25 articles.
1. Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis;Cegielski;Clin Infect Dis,2014
2. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers;Chien;Antimicrob Agents Chemother,1998
3. An HPLC method for levofloxacin determination and its application in biomedical analysis;Czyrski;J Anal Chem,2016
4. Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis;Denti;Antimicrob Agents Chemother,2018
5. The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920;Fridericia;Ann Noninvas Electrocardiol,2003
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Morphology-transforming AuNPs-based fluorescent probe for ultra-low sensitive detection of levofloxacin in urine samples at pH 7.0 through excimer formation;Journal of Molecular Liquids;2024-08
2. A retrospective study of the efficacy and safety of levofloxacin in children with severe infection;Frontiers in Pediatrics;2024-04-05
3. Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis;Clinical Infectious Diseases;2024-02-10
4. Tolerability of Tuberculosis Chemotherapy in Children;Tuberculosis and Lung Diseases;2023-12-24
5. What's new in childhood tuberculosis;Current Opinion in Pediatrics;2023-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3